Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kallmann syndrome (KS) is a developmental genetic disorder characterized by the association of congenital hypogonadotropic hypogonadism (CHH) due to gonadotropin-releasing hormone (GnRH) deficiency, and anosmia or hyposmia (with hypoplasia or aplasia of the olfactory bulbs).
Biomarker and diagnostic research for Kallmann syndrome has been reported in the published literature.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
5 clinical trials registered, 3 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT01601171](https://clinicaltrials.gov/study/NCT01601171) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 5:31 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Kallmann syndrome
— |
Centre Hospitalier Universitaire Vaudois |
RECRUITING |
[NCT04463316](https://clinicaltrials.gov/study/NCT04463316) | GROWing Up With Rare GENEtic Syndromes | — | dr. Laura C. G. de Graaff-Herder | RECRUITING |
[NCT04733274](https://clinicaltrials.gov/study/NCT04733274) | Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing | — | Boston College | UNKNOWN |
[NCT05971836](https://clinicaltrials.gov/study/NCT05971836) | The Molecular Basis of Inherited Reproductive Disorders | — | Stephanie B. Seminara, MD | UNKNOWN |
[NCT01500447](https://clinicaltrials.gov/study/NCT01500447) | Inherited Reproductive Disorders | — | National Institute of Environmental Health Sciences (NIEHS) | RECRUITING |
94 publications have been identified in PubMed for Kallmann syndrome. Research spans Case Report / Case Series (34%), Review / Meta-Analysis (28%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 32 | 34% |
Research summaries | 26 | 28% |
Laboratory research | 14 | 15% |
Disease patterns and progression | 12 | 13% |
Other research | 3 | 3% |
Testing and diagnosis research | 3 | 3% |
Clinical study results | 2 | 2% |
New treatment approaches | 1 | 1% |
Wang Y (2026). [PMID: 41873429](https://pubmed.ncbi.nlm.nih.gov/41873429/). *Hum Reprod Open*. [Review / Meta-Analysis]
Grater L (2026). [PMID: 41621652](https://pubmed.ncbi.nlm.nih.gov/41621652/). *Endocr Pract*. [Review / Meta-Analysis]
Ali JF (2026). [PMID: 41482467](https://pubmed.ncbi.nlm.nih.gov/41482467/). *Cleve Clin J Med*. [Basic Science / Preclinical]
Delbarba A (2026). [PMID: 42178471](https://pubmed.ncbi.nlm.nih.gov/42178471/). *Rev Endocr Metab Disord*. [Review / Meta-Analysis]
Chu S (2026). [PMID: 42168980](https://pubmed.ncbi.nlm.nih.gov/42168980/). *BMC Pediatr*. [Case Report / Case Series]
Lubis JYG (2026). [PMID: 42111331](https://pubmed.ncbi.nlm.nih.gov/42111331/). *Int J Womens Health*. [Case Report / Case Series]
Bellajdel I (2026). [PMID: 41564886](https://pubmed.ncbi.nlm.nih.gov/41564886/). *Clin Exp Reprod Med*. [Case Report / Case Series]
Gentile F (2026). [PMID: 41887743](https://pubmed.ncbi.nlm.nih.gov/41887743/). *AJNR Am J Neuroradiol*. [Epidemiology / Natural History]
Dwyer AA (2026). [PMID: 41206002](https://pubmed.ncbi.nlm.nih.gov/41206002/). *J Clin Endocrinol Metab*. [Review / Meta-Analysis]
Fu Y (2026). [PMID: 41614605](https://pubmed.ncbi.nlm.nih.gov/41614605/). *Eur J Endocrinol*. [Case Report / Case Series]
AI-curated news mentioning Kallmann syndrome
Updated May 18, 2026
A recent bibliometric analysis highlights emerging trends and research hotspots in Kallmann syndrome, providing insights into future research directions. This study aims to guide researchers and stakeholders in understanding the evolving landscape of this rare condition.